The role of tyrosine at the ligand-binding site of the nicotinic acetylcholine receptor.
Identification of the critical residues in a receptor's ligand-binding site provides valuable structural information important for understanding the basis for ligand recognition. The design of specific ligands targeted for receptor action will depend to a great extent on detailed structural knowledge of this kind. Although the nicotinic acetylcholine receptor (nAChR) is perhaps the best characterized of all receptors, the detailed configuration of the ligand-binding site remains unknown. Structural comparisons of nicotinic agonists and antagonists have long predicted a negative subsite on the receptor to interact with the positively charged alkyl-ammonium moiety common to nearly all nicotinic agents. We have used intrinsic fluorescence spectroscopic analyses together with binding studies of selectively modified peptide fragments of the nAChR to suggest that one or two invariant tyrosine residues at positions 190 and 198 on the alpha-subunit provide the critical negative subsite required for ligand binding. Tyrosines may similarly be part of the negative subsite of muscarinic receptors and other neurotransmitter receptors that bind cationic ligands.
Pearce
S F
SF
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
Preston-Hurlburt
P
P
Hawrot
E
E
D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D006801:Humans; D007700:Kinetics; D008024:Ligands; D046911:Macromolecular Substances; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis; D011978:Receptors, Nicotinic / Q000235:genetics / Q000378:metabolism*; D012689:Sequence Homology, Nucleic Acid; D013050:Spectrometry, Fluorescence; D014101:Torpedo; D014443:Tyrosine
D008024:Ligands; D046911:Macromolecular Substances; D010455:Peptides; D011978:Receptors, Nicotinic; D014443:Tyrosine